HK1257467A2 - 癌症細胞檢測和成像系統，過程和製品 - Google Patents

癌症細胞檢測和成像系統，過程和製品

Info

Publication number
HK1257467A2
HK1257467A2 HK18108093A HK18108093A HK1257467A2 HK 1257467 A2 HK1257467 A2 HK 1257467A2 HK 18108093 A HK18108093 A HK 18108093A HK 18108093 A HK18108093 A HK 18108093A HK 1257467 A2 HK1257467 A2 HK 1257467A2
Authority
HK
Hong Kong
Prior art keywords
conjugates
nanodiamonds
wavelength
colour
cells
Prior art date
Application number
HK18108093A
Other languages
English (en)
Inventor
Ka Wing Cheng
Koon Chung Hui
Ching Tom Kong
Original Assignee
Master Dynamic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Master Dynamic Ltd filed Critical Master Dynamic Ltd
Priority to HK18108093A priority Critical patent/HK1257467A2/zh
Priority to PCT/CN2019/092175 priority patent/WO2019242707A1/en
Priority to US17/254,736 priority patent/US20210172953A1/en
Priority to EP19821791.1A priority patent/EP3811060A4/en
Priority to CN201980040942.3A priority patent/CN112469990A/zh
Publication of HK1257467A2 publication Critical patent/HK1257467A2/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6489—Photoluminescence of semiconductors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N2021/6417—Spectrofluorimetric devices
    • G01N2021/6421—Measuring at two or more wavelengths

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK18108093A 2018-06-22 2018-06-22 癌症細胞檢測和成像系統，過程和製品 HK1257467A2 (zh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HK18108093A HK1257467A2 (zh) 2018-06-22 2018-06-22 癌症細胞檢測和成像系統，過程和製品
PCT/CN2019/092175 WO2019242707A1 (en) 2018-06-22 2019-06-21 Cancer cell detection and imaging system, process and product
US17/254,736 US20210172953A1 (en) 2018-06-22 2019-06-21 Cancer cell detection and imaging system, process and product
EP19821791.1A EP3811060A4 (en) 2018-06-22 2019-06-21 CANCER CELL DETECTION AND IMAGING SYSTEM, METHOD AND PRODUCT
CN201980040942.3A CN112469990A (zh) 2018-06-22 2019-06-21 癌细胞检测和成像系统、方法和产品

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18108093A HK1257467A2 (zh) 2018-06-22 2018-06-22 癌症細胞檢測和成像系統，過程和製品

Publications (1)

Publication Number Publication Date
HK1257467A2 true HK1257467A2 (zh) 2019-10-18

Family

ID=68465673

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108093A HK1257467A2 (zh) 2018-06-22 2018-06-22 癌症細胞檢測和成像系統，過程和製品

Country Status (5)

Country Link
US (1) US20210172953A1 (zh)
EP (1) EP3811060A4 (zh)
CN (1) CN112469990A (zh)
HK (1) HK1257467A2 (zh)
WO (1) WO2019242707A1 (zh)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2652562C (en) * 2006-05-17 2015-05-12 Cellumen, Inc. Method for automated tissue analysis
WO2012174173A2 (en) * 2011-06-13 2012-12-20 President And Fellows Of Harvard College Multi-color nanoscale imaging based on nanoparticle cathodoluminescence
US9449377B2 (en) * 2012-10-09 2016-09-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Imaging methods and computer-readable media
CA2935690A1 (en) * 2013-12-31 2015-07-09 Memorial Sloan Kettering Cancer Center Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real-time
US9486163B2 (en) * 2014-02-21 2016-11-08 Verily Life Sciences Llc Silicon-vacancy-doped nanodiamonds for molecular and cellular imaging
US9234892B2 (en) * 2014-05-08 2016-01-12 Agilent Technologies, Inc. Multiple epitope detection in an FFPE tissue section
CN107206108B (zh) * 2014-12-19 2021-08-31 伯拉考成像股份公司 术中成像
CA2979895A1 (en) * 2015-03-18 2016-09-22 Immunobiochem Corporation Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens
CN108136216B (zh) * 2015-10-23 2021-08-24 诺华股份有限公司 对包含肿瘤组织的样品评分的方法
AU2016374246A1 (en) * 2015-12-15 2018-06-28 Cornell University Imaging systems and methods for tissue differentiation, e.g., for intraoperative visualization
CN109804071A (zh) * 2016-08-12 2019-05-24 因维蒂有限公司 用于术前和术中组织定位和可视化的组织特异性标志物
US11085920B2 (en) * 2016-09-06 2021-08-10 Debina Diagnostics, Inc. Nanodiamond particles and related devices and methods
US11719603B2 (en) * 2017-02-28 2023-08-08 University Public Corporation Osaka Collecting apparatus for microscopic objects, collecting container used in collecting apparatus, and method of collecting microscopic objects

Also Published As

Publication number Publication date
WO2019242707A1 (en) 2019-12-26
EP3811060A1 (en) 2021-04-28
EP3811060A4 (en) 2022-03-16
US20210172953A1 (en) 2021-06-10
CN112469990A (zh) 2021-03-09

Similar Documents

Publication Publication Date Title
AU2017225061B2 (en) Biomarkers and methods of treating PD-1 and PD-L1 related conditions
AR039210A1 (es) Panel de diagnostico del cancer
CO2022005077A2 (es) Compuestos moduladores de glp-1r
Mine et al. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors
SV2017005415A (es) Uso de paneles de genes mutantes fgfr en la identificación de pacientes con cáncer que responderán al tratamiento con un inhibidor fgfr
AR037666A1 (es) Metodo para la identificacion de enzimas marcadores tumorales
AR054566A1 (es) Tratamientoombinado de los tumores que expresan el her
ATE335200T1 (de) Diagnose von zellenproliferation sowie screeningverfahren für deren modulatore
WO2003021227A3 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
WO2004079368A3 (en) Markers for colorectal cancer
TW201129847A (en) Optoelectronic device, display and back light module
WO2007005502A3 (en) Methods and compositions for treating diseases targeting cdcp1
WO2021247794A3 (en) B7h3-targeting proteins and methods of use thereof
WO2018191356A3 (en) Adjustable illuminators and methods for photodynamic therapy and diagnosis
HK1257467A2 (zh) 癌症細胞檢測和成像系統，過程和製品
IT201900004737A1 (it) Composti aventi attività enzimatica anti-CDK4/6 e anti-CDK9 per l’inibizione della proliferazione del cancro e relativi metodi di screening per la loro identificazione.
EA202192289A1 (ru) Способы мечения эукариотных клеток многоклеточного организма, а также лечения и/или диагностики рака с использованием модифицированных моносахаридных соединений
WO2003045321A3 (en) MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
Gockel et al. Quality management and key performance indicators in oncologic esophageal surgery
MX2024002720A (es) Nanocuerpos anti-4-1bb.
WO2004037992A3 (en) Mapk7 as modifier of branching morphogenesis and methods of use
WO2019157154A3 (en) Method of identifying tumor specific macromolecular isoforms
RU2008133932A (ru) Клеточная линия аденокарциномы яичника skov-kat
WO2002016939A3 (en) Methods of diagnosis of cancer and screening for cancer modulators
WO2019050149A3 (ko) 전립선특이 막항원 기반 전립선암환자 스크리닝 방법